INSCRIPTA, INC.

Profile

Company Names

INSCRIPTA, INC.
MUSE BIOTECHNOLOGY, INC.

Addresses

5720 STONERIDGE DRIVE, PLEASANTON, CA 94588

5500 CENTRAL AVENUE, SUITE 220, BOULDER, CO 80301

4001 DISCOVERY DRIVE, SUITE N321, UCB 027, BOULDER, CO 80309

2025 ASH STREET, DENVER, CO 80207

Phone Numbers

(925) 694-0333
(303) 775-2354
(720) 759-4088
(720) 480-9235

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$473,943,288.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2022-12-13 
$27,791,098.00 
$27,791,098.00 
$0.00 
Equity 
13
2022-12-12 
$4,399,977.00 
$4,399,977.00 
$0.00 
Equity 
12
2021-11-24 
$1,855,000.00 
$1,855,000.00 
$0.00 
 
11
2021-03-30 
$149,999,970.00 
$149,999,970.00 
$0.00 
Equity 
10
2020-11-13 
$49,999,996.00 
$49,999,996.00 
$0.00 
Equity 
9
2020-10-26 
$8,060,048.00 
$8,060,048.00 
$0.00 
 
8
2019-11-27 
$92,149,960.00 
$124,999,957.00 
$32,849,997.00 
Equity 
7
2019-01-04 
$49,999,979.00 
$49,999,979.00 
$0.00 
Equity 
6
2018-08-31 
$1,146,592.00 
$1,146,592.00 
$0.00 
Equity 
5
2018-02-20 
$55,499,974.00 
$55,499,974.00 
$0.00 
Equity 
4
2017-02-16 
$22,999,995.00 
$22,999,995.00 
$0.00 
Equity 
3
2016-11-23 
$1,005,358.00 
$1,005,358.00 
$0.00 
 
2
2016-04-29 
$6,035,341.00 
$6,035,341.00 
$0.00 
Equity 
1
2016-02-04 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIANNA 
 
DEVORE 
EXECUTIVE OFFICER
DIANNA 
L. 
DEVORE 
EXECUTIVE OFFICER
JUSTIN 
 
FERBER 
EXECUTIVE OFFICER
JASON 
 
GAMMACK 
EXECUTIVE OFFICER
JASON 
T. 
GAMMACK 
EXECUTIVE OFFICER
ANDREW 
D. 
GARST 
PROMOTER
RYAN 
T. 
GILL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MICHAEL 
 
GRAIGE 
EXECUTIVE OFFICER
KRISTALA 
L. 
JONES PRATHER 
DIRECTOR
SRI 
 
KOSARAJU 
EXECUTIVE OFFICER, DIRECTOR
TANYA 
 
LIPSCOMB 
PROMOTER, EXECUTIVE OFFICER, DIRECTOR
RON 
 
MCGRATH 
EXECUTIVE OFFICER
KEVIN 
D. 
NESS 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
STUELPNAGEL 
DIRECTOR
JOHN 
R. 
STUELPNAGEL 
DIRECTOR
ROGER 
 
WYSE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-11-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-10-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-11-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#